Thermo Fisher Scientific and Cerilliant Corporation to Offer Certified Solution Standards for Forensic and Clinical Research Laboratories
News Jan 06, 2010
Scientists performing drugs of abuse analysis in forensic and clinical research laboratories currently face challenges because a large number of different testing methods are used within the industry with no standardization on reagents. Cerilliant's certified Snap-N-SpikeT/ Snap-N-Shoot® solutions for the ToxSpec Analyzer offer the industry standardized solutions that are performance tested for reliability and effectiveness. Cerilliant is a global leader in providing analytical reference standards and controls to the analytical community. The company pioneered the development of ready-to-use, solution-based reference standards provided in a shelf-stable, efficient and accurate format suitable for quantitative applications.
The ToxSpec Analyzer comprises integrated software, hardware and methodologies for forensic toxicology and simplifies the process of running assays while reducing analysis time and increasing confidence in compound identification. This new collaboration will facilitate the development of analytical methodologies designed to meet clinical research and forensic toxicology laboratories' increasingly strict regulatory requirements as well as the need to process assays in a much shorter space of time. The certified solution standards come with complete certificates of analysis and require no preparation or testing, resulting in accelerated turn-around times and significant savings.
The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.READ MORE
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019